Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.
about
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapyCyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerNuclear cyclin B1 in human breast carcinoma as a potent prognostic factorTargeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell.Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Protein subcellular localization profiling of breast cancer cells by dissociable antibody microarray stainingmiR-379 regulates cyclin B1 expression and is decreased in breast cancer.New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cellsThe prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcomeProliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slidesCyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer.Cyclins and cell cycle control in cancer and disease.Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.High cyclin B1 expression is associated with poor survival in breast cancer.Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas.The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.Prognostic value of cyclin E expression in breast cancer: a meta-analysis.Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?
P2860
Q24650994-27862DC8-BCE4-4E34-9721-A814DDE7FF83Q28277288-1B399F6E-341E-4398-A351-D3EBBA8EE550Q28292835-2E9C6D79-1160-42C1-8EAC-A475085FED4DQ30856412-96776361-B504-4709-8000-A78845A4F03EQ33554732-2AA8028A-6EAD-4DE9-8799-41870C48485AQ33672809-39051C89-3A92-426D-AA5A-B98EB7B02A46Q33903965-7000E058-A880-4969-92D6-759B56AF770EQ34798447-EF395776-AB72-42AF-8337-262BF2E27985Q34850908-7AED78B7-BD30-43A4-9330-977DBFE8C04AQ35016962-CD218F36-5634-49E4-B0FA-C1E31F8875F9Q35064038-48F675EB-6B62-4EED-A0A8-395A1F526F8AQ35588426-FECF2C29-09EB-477E-A5FE-DF5BF9433358Q35588576-128830E3-D813-498A-A06A-E0B3F4DC5015Q36175746-12ED8870-3EE4-428C-8D0F-5669BDA25AC6Q36614316-4F0A2379-634F-4204-AF7C-B33CB2D52FB3Q36615243-8828E4CC-3FF2-4FB9-B50A-69BB2BE2ABA8Q36796438-479682DF-51C8-41D0-B87C-081B50717755Q36816034-7DFDFF6E-50BA-4829-A11F-2AF4FA98567CQ37160662-E2699027-5598-42D6-9D8C-7963742E5E65Q37484830-1361D2B8-36AE-4991-BD11-B5A564BBB934Q39943823-5D37303E-F16A-4152-99B6-6D505B47652DQ45751455-DED7A86E-8DF0-44FC-852E-EAE7D772BCE0Q53266957-FEECD540-861D-4774-AA9F-316BF91C141DQ53598681-413F50B1-DFCC-4F27-8D17-3A347E1C0D8AQ54314758-375E3CB0-C269-48AE-8BF7-5676277FCCC3Q57306217-324C230E-1376-4FE5-9C3E-C97048E76FFA
P2860
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Differential prognostic impact ...... h node-negative breast cancer.
@en
type
label
Differential prognostic impact ...... h node-negative breast cancer.
@en
prefLabel
Differential prognostic impact ...... h node-negative breast cancer.
@en
P2093
P2860
P356
P1476
Differential prognostic impact ...... h node-negative breast cancer.
@en
P2093
Bo Baldetorp
Heidi Kühling
Mårten Fernö
Pierre Rudolph
Reza Parwaresch
P2860
P304
P356
10.1002/IJC.11132
P50
P577
2003-07-01T00:00:00Z